Northern Netherlands Region grant for Prof. Quax
Prof. Wim Quax from the Groningen Research Institute of Pharmacy (GRIP) has received a grant worth EUR 200,000 from the Northern Netherlands Region (Samenwerkingsverband Noord-Nederland). Prof. Quax receives this grant for his project ‘Citrus bioflavonoid hesperidin as anti-viral agent for SARS-CoV-2’. With this project, he aims to investigate a possible treatment of corona with hesperidin.
This flavonoid has been suggested to block the connection between the SARS-CoV-2 virus and the ACE2 receptor of human cells. The group of Prof. Quax will analyze how hesperidin reduces the affinity of the spike protein for its target, the ACE2 receptor. Hesperidin is a cheap by-product of citrus fruits and has been used safely in humans for years. Together with project partner Color&Brain, alternative delivery routes and their effects on virus binding will be investigated.
| Last modified: | 01 July 2020 1.31 p.m. |
More news
-
09 October 2024
The hidden costs of duct tape software
Hidden problems in software can lead to major consequences. Paris Avgeriou, Professor of Software Engineering, collaborates with companies to detect such problems and to limit their impact.
-
04 October 2024
European COFUND grant on the origin and evolution of life funds 17 PhD students
The EU has awarded a major grant to a consortium of researchers from the Universities of Groningen and Leiden to research the origin and nature of life.
-
02 October 2024
Biotech Booster grant for FSE researchers
Prof. Marc van der Maarel and Prof. Geert van den Bogaart will receive a Biotech Booster grant of EUR 200,000 from the National Growth Fund Program.